BPC-157 Protocol

Dosing & Research

Last Updated: September 4, 2026

Chemical Identity

Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.55 g/mol
CAS Number: 137525-51-0

Gastrointestinal repair models, Tendon/ligament healing, Angiogenesis and nitric-oxide signaling, Inflammation modulation

Evidence Level

Animal Models Primary

Species Studied

Rat • Mouse • In vitro

Half-Life

4-6 hours

Administration

• Subcutaneous
• Oral

Frequency

Once Daily Or Split Into Twice Daily (morning And Evening)

How It Works

Gastrointestinal repair models
Tendon/ligament healing
Angiogenesis and nitric-oxide signaling
Inflammation modulation

Dosing Structure

Dose

250–500 mcg daily

Frequency

Once Daily Or Split Into Twice Daily (morning And Evening)

Notes

Injection: 200–600mcg daily. Lower end (200–300mcg) may be used for localized targeting near an injury site; higher doses (400–600mcg) for systemic support. Some users prefer splitting dose into twice daily, morning and evening. Oral: 500–1000mcg daily. Benefits are systemic but some recommend injecting near injury for additional benefit. Inject: Belly, thigh, arm. Empty stomach preferred. Strict cycling data is limited. Reassess every 8 weeks.

Example Protocols

Dose: 250–500 mcg daily

Frequency: Once Daily Or Split Into Twice Daily (morning And Evening)

Duration: 4-12 weeks

Off Period: Not listed

Calculate dosing →

Find Research Grade BPC-157

Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.

Vendor One Research Labs

COA Verified

Third-party COA-verified research peptides with published batch testing.

Source Coming Soon

Vendor Two Sciences

Purity Tested

US-based research compound supplier with independent purity testing.

Source Coming Soon

Vendor Three Peptide Co.

Bulk research peptide sourcing with batch-level documentation.

Source Coming Soon

View all recommended vendors →

Protocol Notes

•

Injection: 200–600mcg daily.

•

Lower end (200–300mcg) may be used for localized targeting near an injury site; higher doses (400–600mcg) for systemic support.

•

Some users prefer splitting dose into twice daily, morning and evening.

•

Oral: 500–1000mcg daily.

•

Benefits are systemic but some recommend injecting near injury for additional benefit.

•

Inject: Belly, thigh, arm.

•

Empty stomach preferred.

•

Strict cycling data is limited.

•

Reassess every 8 weeks.

What Is BPC-157?

BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It has been studied extensively in rodent models for its ability to accelerate healing of tendons, ligaments, muscle, and the gastrointestinal tract. Researchers are interested in it because it appears to promote new blood vessel formation and upregulate growth factor receptors at injury sites.

Research Observations - Not Medical Claims

▸Tendon-to-bone healing: A rat Achilles tendon transection model showed significantly accelerated functional recovery and collagen organization vs. controls (PMID: 24380553).
▸Gastric ulcer healing: Systemic BPC-157 administration reduced ulcer area by ~60% in rat gastric lesion models; effect observed at doses as low as 10ng/kg (PMID: 21220747).
▸Muscle healing: Crush injury models in rats showed BPC-157 restored contractile function approximately 30% faster than saline controls.
▸VEGFR2 upregulation: BPC-157 stimulates VEGFR2 expression in fibroblasts, driving angiogenesis - proposed as a key mechanism for its healing effects (PMID: 20171542).
▸No completed human clinical trials have been published to date; all efficacy data derives from animal models.